Potential news of a new partnership might send shares of MannKind temporarily higher, but don’t expect it to be enough to turn the drugmaker’s fortunes around.
Potential news of a new partnership might send shares of MannKind temporarily higher, but don’t expect it to be enough to turn the drugmaker’s fortunes around.